Page 169 - CW E-Magazine (11-2-2025)

News from Abroad News from Abroad

PERFORMANCE TESTING ENGINEERING THERMOPLASTIC
Syzygy Plasmonics and Lotte Chemical conclude Envalior planning PPS compounding facility in Germany

trials of electric ammonia cracker in Korea fi rm formed through the merger of
Envalior, the engineering materials
Lanxess Performance Materials and
Syzygy Plasmonics, the US-based Dr. Suman Khatiwada, co-founder DSM Engineering Materials, is inves-
company seeking to decarbonise chemi- and CTO at Syzygy, said, “This is the ting in a Polyphenylene Sulphide (PPS)
cal production with the power of light, breakthrough that Korea, Japan, and compounding facility in Uerdingen,
and Korea’s Lotte Chemical have com- Eastern Europe have been waiting for. Germany. The facility, expected to
missioned and completed performance They now have an effi cient, proven begin in the second half of 2025, will
testing of the “world’s largest” all-elec- way to crack imported ammonia for cater to growing demand for the com-
tric ammonia cracking system in Ulsan, hydrogen.” pany’s Xytron branded PPS in Europe
South Korea with logistical support from and the Americas.
Sumitomo Corporation of Americas With shipping and logistical support
and Sumitomo Corporation Korea. from Sumitomo Corporation, Lotte According to Envalior, its Xytron
installed a Rigel cell at its facility in material combines a strong set of proper-
This marks the second installation Ulsan, completed plant construction in ties, including excellent chemical and The new facility will provide local Our strategy focuses on increased con-
of Syzygy’s Rigel reactor cell, the other early November, and completed fi eld hydrolysis resistance at elevated tem- supply and additional services to custo- venience and better service, includ-
being located at the company’s demon- testing in December 2024. Syzygy peratures, extremely stable heat ag- mers in Europe while also supporting ing increased agility for new product
stration facility in Houston, Texas provided onsite and remote support ing performance up to 240°C, very the Americas with more diverse supply development and technical support,
(USA). for plant commissioning through the good and stable electrical properties at options. enhanced sample availability, shorter
duration of the test. elevated temperatures, low moisture lead times and improved security
“Building on positive results with compressed, liquifi ed, and transported absorption with high dimensional stabi- “We are observing increased of supply,” said Ms. Angela Zheng,
over 2,500 hours of testing in Houston, at 253°C. Combining nitrogen with “We look forward to working on lity, and inherent fl ame retardance that demand for Xytron, particularly from Global Business Manager for Xytron
the results in Ulsan prove the viability low-carbon hydrogen from regions commercialising this technology in meets UL94 V0. customers in Europe and the Americas. at Envalior.
of using ammonia as a hydrogen carrier with ready access to renewable electri- South Korea. Over the coming years we
and set the stage for energy importing city yields low-carbon ammonia, which plan to work with Syzygy to identify a Indonesian government, ExxonMobil sign MoU on petrochemical
regions like Korea to engage in clean is easier to store and transport. When it good application for building a small complex
ammonia imports,” the companies said. arrives on location, the ammonia can commercial plant together, which will
be cracked with Syzygy’s Ammonia be a big step towards meeting South The Indonesian government and Storage (CCS) technology. It is also used as a centralised carbon storage
Transporting low-carbon hydrogen e-Cracking systems to provide the Korea’s growing hydrogen needs,” said ExxonMobil have signed a Memo- expected to accelerate the development of solution. “The construction of this CCS
to energy importing countries is low-carbon hydrogen energy importers Mr. Hans Shin the Project Manager at randum of Understanding (MoU) to high-performance polymer value chains facility is expected to be able to reduce
diffi cult and costly because it must be need. Lotte Chemical. explore investment potential for the in Indonesia. ExxonMobil is working CO emissions by 90 percent. This is
2
Toray setting up resin compounds facility in Southern development of an advanced petro- with State-energy company PT Pertamina a strategic step towards the fi rst CCS
chemical complex in Indonesia. “With to evaluate the potential for building a project in Indonesia which is expected
China an investment value of $10-bn, we hope CCS hub in Indonesia, which can be to operate soon,” Mr. Airlangga said.
that this project will have a signifi cant
impact on Indonesia’s progress in C2 Pharma receives CEP approval for oxybuprocaine
Japanese chemical fi rm, Toray to begin from April this year. Toray said by focusing on new energy vehicle various sectors,” Indonesia’ Coordinating hydrochloride
Industries, has announced that its subsi- it is also considering a partial production applications, while addressing anticipated Minister for the Economy, Mr. Airlangga C2 Pharma, Ireland-based manu- nition of the CEP. Oxybuprocaine hydro-
diary, Toray Plastics (China) Co., Ltd., transfer from Toray Plastics (Shenzhen) growth in advanced communications, Hartarto, said while addressing the facturer of ophthalmic and niche active chloride, also known as benoxinate, is a
will establish a new production site for Ltd. to the new production site. electrical and electronic applications, MoU signing in Jakarta. pharmaceutical ingredients (APIs), has synthetic local anaesthetic used in ophthal-
high-performance resin compounds to and solar power generation. announced the approval of a Certifi cate mology and otolaryngology for minor
cater automotive electrical components Toray said the growing adoption The petrochemical complex is of Suitability (CEP) for oxybuprocaine surgical procedures. Currently, there
and electrical & electronic connectors. of new energy vehicles, would boost “The new site will not only serve meant to produce high-performance hydrochloride by the European Direc- are only two approved CEPs for oxybu-
demand for high-performance resins, growing demand within China but also polymers to meet the needs of industry torate for the Quality of Medicines and procaine HCl, with C2 Pharma holding
The facility will be located at the particularly for automotive applications. function as a strategic hub for global in Asia, while supporting downstream- Health Care (EDQM). Oxybuprocaine the second. Oxybuprocaine hydro-
premises of another subsidiary – Toray It aims to capture rising demand for these operations, with a particular focus on ing and development of domestic in- hydrochloride will be commercially chloride is manufactured by C2 Pharma’s
Resins (Foshan) Co., Ltd. – in Guang- resins in southern China and expand Southeast Asia,” the company informed dustry. It is designed as a low-emission available to customers in Europe and CMO, Laurus Labs, at their new site in
dong Province, with operations scheduled its business in the Chinese market in a press note. facility by utilising Carbon Capture and other global markets with mutual recog- Anakapalli (Andhra Pradesh India).

168 Chemical Weekly February 11, 2025 Chemical Weekly February 11, 2025 169

Contents Index to Advertisers Index to Products Advertised